Validation of Nafamostat Mesilate as an Anticoagulant in Extracorporeal Membrane Oxygenation: A Large-Animal Experiment

BACKGROUND: Unfractionated heparin is commonly used for anticoagulation in extracorporeal membrane oxygenation (ECMO). Several studies have shown that nafamostat mesilate (NM) has comparable clinical outcomes to unfractionated heparin. This study compared anticoagulation with NM and heparin in a lar...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Sung Joon, Han, Woosik, Song, Hee-Jung, Kim, Cuk-Seong, Jeong, Seong-Mok, Kang, Min Woong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Thoracic and Cardiovascular Surgery 2018
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5894575/
https://www.ncbi.nlm.nih.gov/pubmed/29662809
http://dx.doi.org/10.5090/kjtcs.2018.51.2.114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5894575/
https://www.ncbi.nlm.nih.gov/pubmed/29662809
http://dx.doi.org/10.5090/kjtcs.2018.51.2.114

Ejemplares similares